Amgen Ltd

Industry / private company


Location: Cambridge, United Kingdom (GB) GB

ISNI: -

ROR: https://ror.org/02gvvc992

Show on Map:

Greater Gains in Spine and Hip Strength for Romosozumab Compared With Teriparatide in Postmenopausal Women With Low Bone Mass (2017) Keaveny TM, Crittenden DB, Bolognese MA, Genant HK, Engelke K, Oliveri B, Brown JP, et al. Journal article Development and validation of cardiovascular risk scores for haemodialysis patients (2016) Anker SD, Gillespie IA, Eckardt KU, Kronenberg F, Richards S, Drueke TB, Stenvinkel P, et al. Journal article Inflammation Modifies the Paradoxical Association between Body Mass Index and Mortality in Hemodialysis Patients (2016) Stenvinkel P, Gillespie IA, Tunks J, Addison J, Kronenberg F, Drueke TB, Marcelli D, et al. Journal article Development and validation of a predictive mortality risk score from a European hemodialysis cohort (2015) Floege J, Gillespie IA, Kronenberg F, Anker SD, Gioni I, Richards S, Pisoni RL, et al. Journal article Factors precipitating erythropoiesis-stimulating agent responsiveness in a European haemodialysis cohort: case-crossover study (2015) Gillespie IA, Macdougall IC, Richards S, Jones V, Marcelli D, Froissart M, Eckardt KU Journal article Femoral and vertebral strength improvements in postmenopausal women with osteoporosis treated with denosumab (2014) Keaveny TM, Mcclung MR, Genant HK, Zanchetta JR, Kendler D, Brown JP, Goemaere S, et al. Journal article Frailty and sarcopenia: definitions and outcome parameters (2012) Cooper C, Dere W, Evans W, Kanis JA, Rizzoli R, Sayer AA, Sieber C, et al. Journal article